Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Rite Aid Corp (RADCQ)

Rite Aid Corp (RADCQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Rite Aid Corp PO Box 3165 Harrisburg PA 17105 USA

www.riteaid.com P: 717-761-2633

INDUSTRY GROUPING:

Retail - Drug Stores

Description:

Rite Aid Corporation is on the front lines of delivering health care services and retail products to over one million Americans daily. It provides an array of whole being health products and services for the entire family through retail pharmacies across states. Through Elixir, pharmacy benefits manager, it provides pharmacy benefits and services nationwide. Its key accomplishments include: i) advancing pharmacy strategy, including rebranding retail stores and Elixir, ii) launching a new member portal at Elixir, iii) expanding business, iv) introducing three flagship remodels and v) expanding COVID-19 testing and vaccinations. The company initiates a strategic plan named RxEvolution, which includes significant rebranding, a merchandising overhaul, new marketing and integration and operational initiatives, in both Retail Pharmacy and Pharmacy Services segments.

Key Statistics

Overview:

Market Capitalization, $K 560
Enterprise Value, $K 2,775,000
Shares Outstanding, K 56,026
Annual Sales, $ 24,092 M
Annual Net Income, $ -749,940 K
Last Quarter Sales, $ 5,646 M
Last Quarter Net Income, $ -1,020 M
EBIT, $ -477,450 K
EBITDA, $ -200,870 K
60-Month Beta 1.27
% of Insider Shareholders 1.58%
% of Institutional Shareholders 0.16%
Float, K 55,141
% Float 98.42%
Short Volume Ratio 0.00

Growth:

1-Year Return -98.68%
3-Year Return -99.94%
5-Year Return -99.87%
5-Year Revenue Growth 11.90%
5-Year Earnings Growth -697.50%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -7.39 on 10/17/23
Next Earnings Date 01/01/70
Earnings Per Share ttm -9.50
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Most Recent Dividend 0.115 on 10/14/99
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 04/22/19

RADCQ Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -3.11%
Debt/Equity -1.92
Price/Sales 0.00
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -34.68
Interest Coverage -2.37
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar